Roth Capital Has Bearish Estimate for MGRM FY2029 Earnings

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Research analysts at Roth Capital decreased their FY2029 earnings per share (EPS) estimates for Monogram Orthopaedics in a research report issued on Wednesday, April 16th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings per share of $0.35 for the year, down from their previous forecast of $0.41. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share.

Separately, Roth Mkm boosted their price target on shares of Monogram Orthopaedics from $4.00 to $5.40 and gave the company a “buy” rating in a research report on Tuesday, March 18th.

Monogram Orthopaedics Trading Up 3.1 %

Shares of NASDAQ MGRM opened at $2.70 on Thursday. The firm has a fifty day simple moving average of $2.61 and a two-hundred day simple moving average of $2.50. Monogram Orthopaedics has a 12 month low of $1.82 and a 12 month high of $4.21. The firm has a market capitalization of $95.28 million, a PE ratio of -5.74 and a beta of 0.77.

Monogram Orthopaedics (NASDAQ:MGRM) last posted its earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.03.

Institutional Investors Weigh In On Monogram Orthopaedics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MGRM. Geode Capital Management LLC grew its position in shares of Monogram Orthopaedics by 7.7% in the 4th quarter. Geode Capital Management LLC now owns 226,378 shares of the company’s stock worth $537,000 after buying an additional 16,234 shares during the period. Northern Trust Corp grew its holdings in Monogram Orthopaedics by 110.6% in the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock worth $109,000 after purchasing an additional 24,088 shares during the period. Commonwealth Equity Services LLC grew its holdings in Monogram Orthopaedics by 21.5% in the fourth quarter. Commonwealth Equity Services LLC now owns 41,628 shares of the company’s stock worth $99,000 after purchasing an additional 7,366 shares during the period. Fiduciary Family Office LLC bought a new position in shares of Monogram Orthopaedics during the fourth quarter valued at approximately $70,000. Finally, State Street Corp purchased a new position in shares of Monogram Orthopaedics during the third quarter valued at approximately $62,000. 0.45% of the stock is owned by hedge funds and other institutional investors.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.